JPX · 4588.T
Oncolys BioPharma Inc.
¥7,560+¥160 (+2.16%)
Oncolys BioPharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.5% below the high.
Loading market information…
JPX · 4538.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Fuso Pharmaceutical Industries,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.72% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fuso Pharmaceutical Industries,Ltd.’s forward annual dividend is ¥90 per share, paid semi-annual. The forward yield is 4.27% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Fuso Pharmaceutical Industries,Ltd.’s next earnings report is currently expected on Nov 11, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fuso Pharmaceutical Industries,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Fuso Pharmaceutical Industries, Ltd. is a Japanese firm primarily involved in the development and commercialization of pharmaceutical goods. Their product range encompasses prescription medications, particularly injectables and solutions for artificial kidney dialysis, as well as various medical instruments and apparatus. Additionally, the company participates in real estate leasing. Established in 1937, Fuso Pharmaceutical's corporate headquarters are situated in Osaka, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:03 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥7,560+¥160 (+2.16%)
Oncolys BioPharma Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.5% below the high.
¥559+¥7 (+1.27%)
Astena Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.53% below the high.
¥635-¥1 (-0.16%)
Pharma Foods International Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.12% below the high.
¥737+¥6 (+0.82%)
Medius Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.
¥749-¥17 (-2.22%)
CanBas Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 24.42% below the high.
¥1,150-¥2 (-0.17%)
Wellness Communications Corporation’s quoted price sits in the lower half of its reported 52-week range, 24.34% below the high.
¥972-¥3 (-0.31%)
Ohki Healthcare Holdings Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.97% below the high.
¥260+¥2 (+0.78%)
Taiko Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.98% below the high.
